Page 111 - Developing News Today

DEVELOPING PRECISION MEDICINES FOR THE TREATMENT OF CANCER Corporate Presentation - May 2023 ... | May 10, 2023

BRISBANE, Calif., May 10, 2023 -- Tempest Therapeutics, Inc. , a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms,... | May 10, 2023

Italys Iveco Group has agreed to buy the full ownership of its joint venture with U.S. start-up Nikola developing battery electric and fuel cell heavy-duty trucks, the two companies said on... | May 9, 2023

MIRAMAR, Fla., May 09, 2023 -- HCW Biologics Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the... | May 9, 2023

– Webcast to be Held at 8:00 am ET on May 11, 2023 – NEW YORK, May 9, 2023 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally... | May 9, 2023

Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing biologic immunotherapies intended to enhance function of Regulatory T Cells function while resolving toxic inflammation,... | May 9, 2023

Developing innovative therapies for the treatment of respiratory diseases May 2023 Nasdaq: VRNA |... | May 9, 2023

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for deadly blood diseases - Submits investigational new drug application seeking... | May 9, 2023

-- Recognition, accepted by DENSO President and CEO Koji Arima, honors outstanding innovation in technical fields --TOKYO, May 9, 2023 - (JCN Newswire) - DENSO Corporation accepted the IEEE Corporate Innovation

BOSTON, May 09, 2023 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T... | May 9, 2023